Literature DB >> 12171907

Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.

Sanaa M Nabha1, Ramzi M Mohammad, Mahmoud H Dandashi, Brigitte Coupaye-Gerard, Amro Aboukameel, George R Pettit, Ayad M Al-Katib.   

Abstract

We have previously reported that combretastatin-A4 prodrug (CA4P), anantitubulin/antiangiogenic agent isolated from the South African willow tree Combretum caffrum, induced cell death primarily through mitotic catastrophe in a panel of human B-lymphoid tumors. In this study, we investigated the molecular aspects of the mitotic catastrophe and whether or not it shares the same pathways of apoptosis. For this we studied the effect of CA4P on selected markers of apoptosis [caspases 9 and 3, poly(ADP-ribose) polymerase (PARP), bcl-2, and bax] and G2-M protein regulators (p53, MDM2, 14-3-3sigma, GADD45, cdc2, cdc25, chk1, wee1, p21, and cyclin B1). The chronic lymphocytic leukemia cell line WSU-CLL was used for this purpose. Western blot analysis showed that 24 h of CA4P (5 nM) exposure induces caspase 9 activation and PARP cleavage. However, the addition of Z-Val-Ala-Asp-fluoromethylketone (a general caspase inhibitor) or Z-Leu-Glu(OMe)-His-Asp(OMe)-CH2F (a caspase 9 inhibitor) before CA4P treatment did not block cell death. No change in bcl-2 or bax protein expression was observed. Exposure of WSU-CLL cells to 4 and 5 nM CA4P was associated with overproduction of total p53 and no dramatic change in MDM2, 14-3-3sigma, GADD45, the cyclin-dependent kinase cdc2, its inhibitory phosphorylation, the cdc2-inhibitory kinase (wee1), chk1, or cdc25 hyperphosphorylation. The overaccumulation of p21 and cyclin B1 protein was obvious at 24 h. Furthermore, CA4P treatment showed an increase in the expression of a marker of mitosis (mitotic protein monoclonal-2 antibody) and an overaccumulation of the cyclin B in the nucleus. Our findings suggest that CA4P induces mitotic catastrophe and arrest of WSU-CLL cells mostly in the M phase independent of p53 and independent of chk1 and cdc2 phosphorylation pathways. Apoptosis is a secondary mechanism of death in a small proportion of cells through activation of caspase 9 and PARP cleavage. The two mechanisms of cell death, i.e., mitotic catastrophe and apoptosis, are independent of each other in our model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171907

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  20 in total

1.  Mitotic cell death in BEL-7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication.

Authors:  Yue-Xin Liang; Wei Zhang; Dian-Dong Li; Hui-Tu Liu; Ping Gao; Yi-Na Sun; Rong-Guang Shao
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

2.  Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.

Authors:  Cheng-Huang Shen; Jia-Jen Shee; Jin-Yi Wu; Yi-Wen Lin; Jiann-Der Wu; Yi-Wen Liu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Novel combretastatin A-4 derivative XN0502 induces cell cycle arrest and apoptosis in A549 cells.

Authors:  Hong Zhu; Jun Zhang; Na Xue; Yongzhou Hu; Bo Yang; Qiaojun He
Journal:  Invest New Drugs       Date:  2010-03-30       Impact factor: 3.850

4.  Exposure of human lung cancer cells to 8-chloro-adenosine induces G2/M arrest and mitotic catastrophe.

Authors:  Hong-Yu Zhang; Yan-Yan Gu; Zeng-Gang Li; Yu-Hong Jia; Lan Yuan; Shu-Yan Li; Guo-Shun An; Ju-Hua Ni; Hong-Ti Jia
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

5.  Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor.

Authors:  Lih-Ching Hsu; David E Durrant; Ching-Chun Huang; Nai-Wen Chi; Riccardo Baruchello; Riccardo Rondanin; Cinzia Rullo; Paolo Marchetti; Giuseppina Grisolia; Daniele Simoni; Ray M Lee
Journal:  Invest New Drugs       Date:  2011-06-08       Impact factor: 3.850

6.  RASSF7 is a member of a new family of RAS association domain-containing proteins and is required for completing mitosis.

Authors:  Victoria Sherwood; Ria Manbodh; Carol Sheppard; Andrew D Chalmers
Journal:  Mol Biol Cell       Date:  2008-02-13       Impact factor: 4.138

7.  The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death.

Authors:  Isabelle Petit; Matthias A Karajannis; Loic Vincent; Lauren Young; Jason Butler; Andrea T Hooper; Koji Shido; Hermann Steller; David J Chaplin; Eric Feldman; Shahin Rafii
Journal:  Blood       Date:  2007-11-16       Impact factor: 22.113

8.  The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell death.

Authors:  Chryso Kanthou; Olga Greco; Anna Stratford; Ian Cook; Richard Knight; Omar Benzakour; Gillian Tozer
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

9.  Stilbene 5c, a microtubule poison with vascular disrupting properties that induces multiple modes of growth arrest and cell death.

Authors:  M R Alotaibi; B Asnake; Xu Di; M J Beckman; D Durrant; D Simoni; R Baruchello; R M Lee; E L Schwartz; D A Gewirtz
Journal:  Biochem Pharmacol       Date:  2013-10-19       Impact factor: 5.858

10.  Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells.

Authors:  Ho-Hsing Tseng; Qiu-Yu Chuah; Pei-Ming Yang; Chiung-Tong Chen; Jung-Chi Chao; Ming-Der Lin; Shu-Jun Chiu
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.